This paper describes the first large scale identification of parts of the human chromosome that control gene expression in parts of the embryonic brain. This information can be used to…
The fate, migration, and repair potential of a stem cell is driven by a combination of intrinsic properties, such as the type, source, and maintenance/differentiation of the cell in vitro,…
Our lab is known for its discovery of the family of nuclear hormone receptors (NHRs) that use vitamins/hormones to control genes and thereby regulate embryonic development, cell growth, physiology and…
The CIRM Diabetes Disease Team is developing a stem cell-derived cell therapy to treat insulin-dependent diabetes. The ultimate goal under the 4-year CIRM Award DR1-01423 is to file an IND…
The CIRM Diabetes Disease Team is developing a cell therapy to treat insulin-dependent diabetes. The ultimate goal under CIRM Award DR1-01423 is to file an IND with the FDA to…
The CIRM Diabetes Disease Team is developing a cell therapy to treat insulin-dependent diabetes. The ultimate goal under CIRM Award DR1-01423 is to file an IND with the FDA to…
Pluripotent stem cells (hPSCs) carry the potential to grow and expand indefinitely while concomitantly harboring the unique ability to generate all mature cell types. These two properties of hPSCs present…
Human pluripotent stem cells (hPSCs) and their derivatives represent the only research tool to study human development. As such, these cells allow us to study the progression of diseases at…
